|
| Region/country | Main NTM species | % of total isolates | NTM diversity | Years | Clinical relevance/comments | Overall trend |
|
| Europe/England (review) [35] | M. avium-intracellulare | 42.9 | 15 species were identified and two isolates were not properly identified. | 1995–2006 | Pulmonary and extrapulmonary diseases. | Increase in SGM. |
| M. malmoense | 13.7 |
| M. kansasii | 12.5 |
| Others | — |
|
| Europe/Italy (review) [34] | M. avium | 42.9 | 13 species were identified, an increasing proportion of unidentified species. | 2004–2014 | 76.2% of clinical isolates were extracted from pulmonary specimens. | Increase in SGM. |
| M. intracellulare | 14.3 |
| M. gordonae | 11.6 |
| Others | — |
|
| America/USA (article) [36] | MAC | 40.9 | 22 species were identified. | 2001–2009 | 17% were pulmonary cases and the remaining were due to extrapulmonary infections. | Increase in SGM. |
| M. gordonae | 28.7 |
| M. abscessus | 4.5 |
| Others | — |
|
| America/Canada (article) [95] | MAC | 62 | Not clearly stated but approximately 8 species. | 1997–2003 and 2007 | Mainly pulmonary infections. | Increase in SGM. |
| M. xenopi | 23 |
|
| Australia/Queensland (article) [37] | MAC | 72 | 15 species were identified. | 1999–2005 | Pulmonary and extrapulmonary infections. | Increase in SGM. |
| M. kansasii | 8 |
|
| Asia/China (article) [39] | M. kansasii | 45 | 25 species were identified. | 2007–2012 | Mainly pulmonary cases. | Increase in SGM. |
| M. intracellulare | 20.8 |
| M. chelonae/abscessus | 14.9 |
| Others | — |
|
| Asia/South Korea (article) [40] | MAC | 53 | 10 species were identified and 2.5% unidentified. | 2001–2011 | Mainly pulmonary. | Increase in RGM. |
| M. abscessus-massiliense | 25 |
| M. fortuitum | 6 |
| Others | — |
|
| Asia/India (article) [38] | M. abscessus | 31.3 | 13 species were identified. | 2013–2015 | 79.8% pulmonary and 18.2% extrapulmonary. | Increase in RGM. |
| M. fortuitum | 22 |
| M. intracellulare | 13.9 |
| M. chelonae | 9.1 |
| Others | — |
|
| Middle East/GCC State (articles) [17–21] | M. fortuitum | 29 | A total of 18 species were identified from clinical specimens, though data remain scarce. | 1991–2013 | Pulmonary and extrapulmonary. | Increase in RGM. |
| MAC | 25 |
| M. abscessus | 17 |
| Others | — |
|
| Africa/Zambia (articles) [42, 96] | M. lentiflavum | 34 | Not very clear but approximately 18 species were identified. | 2015 and March to August 2001 | Mainly pulmonary. | Not very clear. |
| MAC | 15 |
|
